News
-
-
-
COMMUNIQUÉ DE PRESSE
Feasibility Study with Evonik Confirms LEON’s FR-JET Technology’s Performance in Advanced Nanoparticle Manufacturing for Drug Delivery
Feasibility study confirms LEON's FR-JET technology's exceptional performance in advanced nanoparticle manufacturing for drug delivery, validated by Evonik Canada Inc -
-
-
COMMUNIQUÉ DE PRESSE
leon-nanodrugs secures funds in a series D financing to broaden portfolio in first single-use high throughput production systems for nanoencapsulation
leon-nanodrugs secures funds in a series D financing round to expand nanoencapsulation portfolio for genetic material & active substances, aiming for efficient GMP manufacturing -
-
-
COMMUNIQUÉ DE PRESSE
Technical Evaluation by CMAC Introduces LEON’s Cutting-Edge Formulation Technology
Technical Evaluation by CMAC introduces LEON's cutting-edge formulation technology, revolutionizing lipid nanoparticle production for drug delivery. Joint effort with experts proves success in in-vitro and in-vivo tests -
COMMUNIQUÉ DE PRESSE
leon-nanodrugs appoints Dr. Hans Frickel as Chief Executive Officer
